News

Delhi’s APAC Biotech bags patent for personalized immunotherapy based cancer treatment

APCEDEN – APAC’s immunotherapy product, has already been approved by the Indian FDA for treating cancer. The company has further announced it will conduct clinical trials for highly aggressive brain tumors

Read More

Jul 28, 2020

By : Team ABLE

Serum Institute’s Adar Poonawalla hopes to launch COVID-19 vaccine by November

Mr Poonawalla had told NDTV that the vaccine will take probably two to two-and-half months to complete. He is hopeful that the vaccine will be launched by November, if the trials are positive and if the regulatorDCGI approves it.

Read More

Jul 22, 2020

By : Team ABLE

Richcore LifeSciences to expand its recombinant protein manufacturing capability

Richcore’s expansion will go a long way in augmenting indigenous manufacturing of biomedical resources and strengthening domestic supply chain

Read More

Jul 22, 2020

By : Team ABLE

Jubilant Life Sciences Limited announces approval of ‘JUBI-R’ (remdesivir) in India for the treatment of COVID-19

Jubilant’s Remdesivir product will be marketed under the brand name ‘JUBI-R’ in India and will be made available in 100 mg vials (injectable).

Read More

Jul 22, 2020

By : Team ABLE

AIIMS conducts human clinical trials of Bharat Biotech’s Covid-19 vaccine candidate Covaxin

The institute will select healthy participants with no comorbidities and without a history of Covid-19.

Read More

Jul 20, 2020

By : Team ABLE

 

voice for BT and BEST 2026

Applications Open now

Apply for the Indo-Boston Biotech Bridge Award

Calling All Indian Biotech Startups

Focus Areas

Highlights